Glenn Dranoff, MD, a professor of medicine at Dana-Farber Cancer Institute and Harvard Medical School in Boston, MA, has been named the founding editor-in-chief of Cancer Immunology Research. Published by the American Association for Cancer Research, the journal will launch online at the organization's annual meeting in April, followed by monthly print issues beginning in June.
The leader of the Dana-Farber/Harvard Cancer Center Program in Cancer Immunology, Dranoff has devoted his research efforts to understanding tumor immunity and to the development of cancer vaccines.
Karen E. Knudsen, PhD, began a 5-year term as editor-in-chief of Molecular Cancer Research this month. She succeeds Michael B. Kastan, MD, PhD, executive director of the Duke Cancer Institute in Durham, NC.
Knudsen is a professor in the departments of cancer biology, urology, and radiation oncology at Philadelphia's Thomas Jefferson University and deputy director for basic science at the affiliated Kimmel Cancer Center. In addition to authoring book chapters and dozens of peer-reviewed articles, she has held several leadership roles on scientific publications, including Cancer Research.
Richard Nakamura, PhD, has been chosen as the new director of the NIH's Center for Scientific Review (CSR). He will lead 450 scientists and administrative staff, overseeing their efforts to manage 80,000 NIH grant applications a year, the majority of which are reviewed by CSR peer review groups. The CSR holds 1,600 review meetings a year.
Prior to joining the CSR in 2011, Nakamura spent 32 years at the National Institute of Mental Health, serving as both its scientific and deputy director.
For more news on cancer research, visit Cancer Discovery online at http://CDnews.aacrjournals.org.